Iván Vergara

Learn More
BACKGROUND New drugs often substitute others cheaper and with a risk-benefit balance better established. Our aim was to analyse the diffusion of new drugs during the first months of use, examining the differences between family physicians and specialists. METHODS Prescription data were obtained of cefditoren, duloxetine, etoricoxib, ezetimibe,(More)
  • 1